AVCRF — Avricore Health Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1355736 ·
Last close
$0.03
Market Cap
$3.29M
52W High
$0.06
52W Low
$0.03
ADV30
98,445
Next earnings
2026-05-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 33,451 | -7,307 | -341,979 | -943,089 | 563,125 | 227,918 | 173,561 |
| Sep 2025 | 37,680 | -52,600 | -379,084 | -379,288 | 1,329,290 | 531,752 | 35,885 |
| Jun 2025 | 28,692 | -48,095 | -471,563 | -459,008 | 1,667,495 | 855,190 | 46,546 |
| Mar 2025 | 434,061 | 346,297 | -73,810 | -77,362 | 2,139,345 | 1,269,705 | 187,057 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-789,933
Investing CF
$-114,362
Financing CF
$0
CapEx
$-114,362
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-34,263,284
Inventory
$0
Receivables
$37,332
ST Investments
$10,000
EBIT TTM
$-1,266,436
Pretax Income TTM
$-1,858,747
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$533,884
EBITDA
$-1,086,994
Free Cash Flow
$-305,808
Enterprise Value
$3,048,931
Total Cash
$237,918
Total Debt
$0
Shares Out
101,289,664
Trailing EPS
$-0.01
Book Value
$0.00
ROE
-157.7%
ROA
-53.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 533,884 | -1,266,436 | -1,858,747 | 563,125 | 173,561 | — | -789,933 |
| Dec 2024 | 4,785,711 | 139,348 | -668,977 | 2,298,544 | 330,817 | — | 1,004,615 |
| Dec 2023 | 3,485,147 | -687,245 | -701,215 | 2,538,205 | 529,218 | — | 660,403 |
| Dec 2022 | 1,768,374 | -812,524 | -818,228 | 2,568,983 | 604,893 | — | -437,832 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AZTR | Azitra, Inc. | $3.40M | $0.21 | — |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $3.43M | $0.59 | — |
| BIXT | BIOXYTRAN, INC | $3.47M | $0.03 | — |
| CASIF | CASI Pharmaceuticals, Inc. | $3.08M | $0.15 | — |
| GRI | GRI Bio, Inc. | $3.61M | $2.04 | — |
News headlines (Yahoo Finance, 1h cache)
Avricore Health Announces $1.25 Million Financing
2026-05-20 10:55 · Yahoo
Avricore Health Outlines UK Expansion Roadmap for HealthTab Platform
2026-04-21 12:45 · Yahoo
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
2026-04-21 10:30 · Yahoo
HealthTab™ to Expand Across North East London
2026-01-14 14:46 · Yahoo
HealthTab™ to Power NHS Pilot
2025-11-27 22:00 · Yahoo
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
2025-07-10 11:00 · Yahoo
Avricore Grants Options
2025-06-14 05:05 · Yahoo
Avricore Appoints Rodger Seccombe as CEO
2025-06-05 11:00 · Yahoo
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
2025-06-02 11:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.